Table 3.
Estimated HIV prevalence at endemic equilibrium among people who inject drug in Middle East and North Africa.
| No datasets | Mean HCV prevalence | HIV epidemic state among PWIDa[2] | Most recent representative HIV prevalence [2] | Estimated endemic HIV prevalence using regression | Estimated endemic HIV prevalence using meta-analysis | HIV epidemic potential | |||||
| % | 95% CI | % | 95% CI | ||||||||
| Afghanistan | 13 | 34.2% | Emerging | 4.4% | 12.5 | 8.7–18.0 | 12.3 | 9.6–15.9 | Medium | ||
| Egypt | 1 | 63.0% | Emerging | 7.2% | 20.7 | 16.1–26.6 | 22.7 | 17.6–29.3 | High | ||
| Iran | 42 | 47.1% | Established | 15.1% | 15.7 | 11.8–20.9 | 17.0 | 13.2–21.9 | Low | ||
| Lebanon | 2 | 29.0% | Low-level | 0.0% | 11.4 | 7.7–17.1 | 10.5 | 8.1–13.5 | High | ||
| Morocco | 2 | 57.6% | Emerging | 13.0% | 18.9 | 14.6–24.3 | 20.8 | 16.1–26.8 | Medium | ||
| Palestine | 1 | 43.8% | Low-level | 0.0% | 14.8 | 10.9–20.0 | 15.8 | 12.2–20.4 | High | ||
| Pakistan | 19 | 60.7% | Emerging | 25.2% | 19.9 | 15.5–25.6 | 21.9 | 17.0–28.3 | Low | ||
| Saudi Arabia | 3 | 60.5% | Unknown | 0.6% | 19.8 | 15.4–25.5 | 21.8 | 16.9–28.2 | High | ||
| Syria | 1 | 60.5% | Low-level | 0.5% | 19.8 | 15.4–25.5 | 21.8 | 16.9–28.2 | High | ||
| Tunisia | 3 | 22.6% | Low-level | 3.0% | 10.2 | 6.5–16.0 | 8.2 | 6.3–10.5 | Medium | ||
CI, confidence interval; HCV, hepatitis C virus.
a
Overall current HIV epidemic state among PWID at country-level.